A study showed that baseline MAPK signaling activity conferred intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid up-regulation of hnRNP K (Eder et al., 2017). The gene discussed is KRAS; the disease is colorectal carcinoma.